Zenflow key facts
as of Oct 2026- Developer of a medical device designed to offer devices for urinary obstruction caused by an enlarged prostate.
- Zenflow is valued at approximately $78.5M as of Oct 2026, set at its later-stage round, Nov 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $92.6M across 3 recorded rounds; the latest was Early Stage VC ($19.4M) in Nov 2024.
- Notable investors include Y Combinator, US National Science Foundation, MedTech Innovator, StartX (US), F-Prime Capital — 32 tracked in total.
- Zenflow has filed 5 Form Ds with the SEC since 2017, most recently Nov 2024 ($19.4M sold to 36 investors).
- Status: Privately Held (backing).
Valued at $78.5M at its later-stage round, Nov 2024. Nothing has traded since.
- ·The complete investor list: 32 names
- ·Watch Zenflow: the Monday email on marks, rounds and moves
Zenflow funding rounds
3 roundsWho backs Zenflow
32+Zenflow valuation
Zenflow was valued at $78.5 million at its later-stage round in Nov 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Zenflow raised?
Zenflow has raised $92.6 million across 3 recorded rounds since 2017. The largest was a $31.5 million early-stage round in Sep 2017; the most recent was a $19.4 million early-stage round in Nov 2024.
Zenflow has filed 5 Form Ds with the SEC since 2017, most recently in Nov 2024 ($19.4 million sold to 36 investors).
Zenflow investors
32 investors are on record for Zenflow, including Y Combinator, US National Science Foundation, MedTech Innovator and StartX (US). By type, the record holds 6 venture capital firms and 1 angel investor. The early-stage round in Nov 2024 drew 36 investors.
About Zenflow
Developer of a medical device designed to offer devices for urinary obstruction caused by an enlarged prostate. The company offers treatment that has been designed with the patient experience in mind and relies on a small spring-like coil that gently props open the urethra, restoring its normal function while preserving the natural anatomy, helping patients experience less invasive and less painful treatment.
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2014
- Employees
- 33
- Website
- zenflow.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.